Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00416338
Other study ID # CRE-2006.401-T
Secondary ID
Status Terminated
Phase Phase 4
First received December 27, 2006
Last updated May 9, 2007
Start date January 2007
Est. completion date May 2007

Study information

Verified date April 2007
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Peritoneal dialysis accounts for more than 70% of the dialysis modality in Hong Kong. Exit site infection (ESI) is one of the causes leading to peritoneal catheter removal. Appropriate exit-site care can prevent ESI. As the presence of a causative organism is essential in ESI, eliminating organism invasion may be useful in preventing ESI. In the present study, an exit site care method aiming at preventing organism invasion is developed to investigate its effectiveness in reducing ESI. It is also hoped the present study can help to develop an exit site care method that can reduce the frequency of exit site dressing so as to reduce the burden of patients and to improve their quality of life.

We’ll recruit one hundred new chronic peritoneal dialysis patients into the study. The patients will be divided into two groups. One group of the patients will use film-dressing method (F) and the other group will use simple gauze dressing method (G). F group patients will have the exit site covered with a dressing film and keep it intact for 7 days after having the exit site cleaned with antiseptic solution. G group patients will clean the exit site with antiseptic solution and change the simple gauze dressing daily.

The outcomes of the two groups will be compared. The outcome will be expressed in terms of exit site infection free period, peritonitis free period and exit site condition classification. Patient subjective quality of life will also be compared at first and twelfth month.


Recruitment information / eligibility

Status Terminated
Enrollment 11
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- chronic renal failure patients with peritoneal catheter newly inserted

Exclusion Criteria:

- Patients have exit-site infection before stitches removal or presence of signs and symptoms of exit-site infection at the time of remove stitches.

- Patients plan to move out of PWH or transplant soon after catheter insertion.

- Patients have known history of allergy to adhesives / tapes.

- Extremely non-compliant patients.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
film dressing by adhesive


Locations

Country Name City State
Hong Kong Department of Medicine & Therapeutics, Prince of Wales Hospital Shatin

Sponsors (1)

Lead Sponsor Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Exit site infection.
Secondary Patient satisfaction / quality of life.